Wani magungunan nazarin halittu wanda ba zai iya yin amfani da shi ba don rudun maganin jini
Adalimumab, wanda aka fi sani da Humira, wani magani ne na kwayar halitta wanda ke aiki ta hanyar hana wani sinadaran da ake kira TNF-alpha . Yawancin lokaci, TNF-alpha yana taimakawa wajen kamuwa da kamuwa da cuta, amma yana da yawa, zai iya haifar da kumburi mai zafi da kuma haɗar haɗuwa mai tsanani (watau bayyanar cututtuka na cututtuka na rheumatoid da sauran siffofin ƙwayar ƙwayar ƙwayar cuta ). Magunguna irin su Humira sun taimaka magungunan marasa lafiya na rheumatoid ta hanyar sauya ciwo, inganta aikin haɗin gwiwa, da kuma jinkirin ci gaban ci gaban.
Bayani
Humira wani ɓangare ne kawai wanda yake da alaƙa . Wannan yana nufin cewa, kodayake an yi shi a cikin tsarin ilimin halitta ba na mutum ba, kayan shafa na kwayoyi masu kama da kwayoyi sune daidai da na kwayoyin halitta. Kuma wannan Humira wanda ya bambanta daga wanda aka haramta ta TNF wanda aka yarda a gabanta - an samu nauyin haɓakar gina jiki daga wani ɓangare na mutum ba tare da wani mutum ba.
A shekara ta 2002, Cibiyar Abinci da Harkokin Kiyaye na Amurka (FDA) ta amince da farko da Humira a matsayin magani ga cututtuka na rheumatoid. Yana daya daga cikin magungunan kwayoyin halitta wanda ke toshe TNF-alpha, ciki har da:
- Enbrel (Etanercept) : Jirgin farko na anti-TNF da FDA ta amince don maganin cututtuka da wasu cututtukan cututtuka a cikin 1998.
- Remicade (Infliximab) : Gidan mai na biyu TNF ya yarda da shi ta hanyar FDA a 1999.
- Simponi (Golimumab) : FDA ta amince da ranar 24 ga Afrilu, 2009.
- Cimzia (Certolizumab Pegol) : FDA ta amince da ranar 14 ga Mayu, 2009.
Bayyanawa
Humir yakan ba da magungunan subwayaneous (ƙarƙashin fata) sau ɗaya kowace mako biyu. Kwararren likita zasu iya ba da shawara don su shige shi a kowane mako idan kowane kwanaki 14 bai isa ba.
An fara samuwa a cikin wani amfani guda ɗaya, cike da sakonji da aka cika. An yi amfani da tsarin sauƙaƙe wanda aka tsara, wanda aka sani da Humira Pen.
Kwararren shawarar, duk da haka, yana da 40mg a matsayin mai yin amfani da subcutaneous ta amfani da sirinji da aka cika ko Humira pen kowane mako. Methotrexate , wasu DMARDs marasa ilimin halitta, glucocorticoids , kwayoyin anti-inflammatory wadanda basu da magunguna (NSAIDs) , ko analgesics (magunguna) zasu iya ci gaba yayin da ake bi da su tare da Humira. Duk da haka, ba za a yi amfani da sauran DMARDs ba.
Shaidawa
An kara karin alamun Humira tun lokacin da FDA ta amince da shi. Ana iya wajabta a bi da bi:
- Rheumatoid Arthritis
- Ankylosing Spondylitis
- Psritic Arthritis
- Ƙananan Ƙwayar Ciwon Ƙari na Yara
- Plaque Psoriasis
- Ulcerative Colitis
- Babbar yara da kuma ƙwayar cuta na Crohn
- Hidradenitis Suppurativa
Hanyoyin Gaba
Hanyoyin da ke tattare da Humira sun hada da:
- Maƙarƙashiyar shafin intanet
- Rash
- Ciwon kai
- Cutar baƙin ciki ko tashin hankali
- Ciwon huhu
Ayyukan Mugunta
Saboda yana hana amsawar rigakafi a cikin jikin da ke fama da kamuwa da cuta, Humira ya hade da cututtuka masu tsanani, irin su tarin fuka, sepsis, da cututtuka na fungal. Yana iya kara damuwa da bayyanar cututtuka na cututtukan cututtuka (misali, lalata ƙaddara). A cikin gwaji, wasu marasa lafiya sun sami yawan ciwon daji da lymphoma a tsawon watanni 24.
Wanda bai kamata ya dauki Humira ba
Dole ne marasa lafiya suyi amfani da Humira da sanadiyar da aka sani game da miyagun ƙwayoyi ko abubuwan da aka gyara. Har ila yau, marasa lafiyar da suke ciki ko hayarwa ba za su yi amfani da shi ba.
Kada a sanya wa miyagun ƙwayoyi magani ga marasa lafiya wanda ke da kamuwa da cuta ko kuma marasa lafiya wadanda aka riga sun kamu da kamuwa da cuta, ciki har da marasa lafiya da marasa ciwon sukari ko marasa lafiya wanda ke da tarihin ciwo na ci gaba.
Faɗa wa likitanku
- Idan kana da kamuwa da cuta
- Idan ka kamu da cutar Hepatitis B ko kuma mai ɗauka (Humira an hade shi tare da mayar da cutar Hepatitis B)
- Idan kuna da numbness, tingling, ko sikelicis da yawa ko kuma tsakiyar tsarin jin dadi
- Idan an bi ku don zuciya rashin cin nasara
- Kafin samun kowane maganin alurar riga kafi ko tiyata
Don bayar da rahoto game da halayen haɗari, za a iya tuntuɓar AbbVie Inc.at 1-800-633-9110 ko FDA a 1-800-FDA-1088 ko www.fda.gov/medwatch.
Sources:
Zashin, MD, Scott J .. Arthritis Ba tare da Pain ba. Sarah Allison Publishing Company.
Humira . Cibiyoyin dakunan Abbott. Bayyana Bayani. 2016.